RecruitingFemale onlyEN originalOvarian cancer

Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The findings from this study have the potential to serve as a foundation for evaluating the current practices related to surgical procedures, systemic therapies, hyperthermic intraperitoneal chemotherapy, and referrals to geneticists for OC patients. By identifying the strengths and weaknesses of the existing care, this project intends to generate valuable insights that can lead to the implementation of quality parameters for the treatment of ovarian cancer in the country.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Pacjentki powyżej 18. roku życia.
  • Pacjentki z nowo zdiagnozowanym rakiem jajnika w stadium od IA do IVB.
  • Pacjentki z rakiem jajnika, który nie ustąpił po leczeniu lub powrócił od stycznia 2021 roku.
  • Pacjentki bez względu na rodzaj histologiczny raka.

✗ Disqualifies

  • Pacjentki z tzw. "łagodnymi" (granicznymi) guzami jajnika.
  • Pacjentki w ciąży.
  • Pacjentki z innym guzem współistniejącym lub drugim pierwotnym nowotworem w ciągu ostatnich 5 lat (z wyjątkiem raka tarczycy i raka skóry niezwiązanego z czerniakiem).

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
June 29, 2026
Sex
Female only

Locations (18)

Research Site

Barretos, Brazil

Research Site

Belo Horizonte, Brazil

Research Site

Belo Horizonte, Brazil

Research Site

Brasília, Brazil

Research Site

Curitiba, Brazil

Research Site

Goiânia, Brazil

Research Site

João Pessoa, Brazil

Research Site

Natal, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Recife, Brazil

Research Site

Rio Branco, Brazil

Research Site

Rio de Janeiro, Brazil

Research Site

Salvador, Brazil

Research Site

São Jose Dos Campos, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Trial contact

AstraZeneca Clinical Study Information Center

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.